4:56 pm Revance Therapeutics announces positive results from the RT002 Phase 1/2 study in glabellar (frown) lines
View todays social media effects on RVNC
View the latest stocks trending across Twitter. Click to view dashboard
See who Revance is hiring next, click here to view
